Horizon Therapeutics Newswire (Page 7)

Horizon Therapeutics Newswire (Page 7)

Comprehensive Real-Time News Feed for Horizon Therapeutics. (Page 7)

Results 121 - 140 of 304 in Horizon Therapeutics

  1. Gold Af Registry to Capture Real-World Insights Using Medtronic...Read the original story

    Apr 7, 2015 | PR-inside.com

    April 7, 2015 - Medtronic plc today announced the first patient enrollment in the GOLD AF Registry, a first-of-its-kind, prospective, observational clinical study of its Phased Radiofrequency Ablation technology for treating patients with symptomatic atrial fibrillation . The multicenter registry will provide real-world insights into the procedural use and treatment outcomes of the Pulmonary Vein Ablation Catheter GOLD, multi-electrode ablation catheter and other catheters that comprise Medtronic's Phased RF technology.

    Comment?

  2. Medical device maker settles lawsuit for $4.4MRead the original story w/Photo

    Apr 3, 2015 | Salt Lake Tribune

    Minneapolis a Medtronic has agreed to pay $4.4 million to settle a lawsuit filed by the federal government accusing the company of selling medical devices made in China and Malaysia to the U.S. military. Federal law requires that devices sold to the military be manufactured in the U.S. or its international trading partners.

    Comment?

  3. Medtronic settles federal suit over "Buy American" lawRead the original story w/Photo

    Apr 3, 2015 | Business Journal

    Medtronic Inc. will pay $4.4 million to settle a federal lawsuit that it falsely labeled medical devices from China and Malaysia as made in the United States before selling them to the U.S. military. The Star Tribune has a report on the case , which alleged that the company knowingly labeled Chinese-bade spinal surgery devices as "manufactured in Memphis," where its spinal unit is based.

    Comment?

  4. Medical Device Maker Settles Lawsuit For $4.4 MillionRead the original story w/Photo

    Apr 3, 2015 | CBS Local

    TV is part of CBS Television Stations, a division of CBS Corp. and one of the largest network-owned station groups in the country. Click here for WCCO-TV news stories Send us your breaking news tips [...] 830 WCCO Welcome to News Radio 830 WCCO on CBSMinnesota.com! WCCO is part of CBS Radio, a division of CBS Corp. and one of the largest network-owned station groups in the country.

    Comment?

  5. Medtronic to Pay U.S. $4.4 Million to Settle LawsuitRead the original story w/Photo

    Apr 2, 2015 | KSTP

    Medical-device maker Medtronic has reached a settlement with the United States resolving allegations that the company with headquarters in Minneapolis illegally sold medical devices made overseas. Medtronic Sofamor Danek USA, has agreed to pay $4.4 million to settle the case.

    Comment?

  6. Medtronic snaps up diabetes clinic and research centerRead the original story w/Photo

    Apr 2, 2015 | Business Journal

    The deal is part of Medtronic's expansion into providing health care services . Much of the med-tech giant's activities on that front have centered in Europe.

    Comment?

  7. Medtronic Announces New Spyral HTN Global Clinical Trial Program for Renal DenervationRead the original story

    Apr 1, 2015 | PressReleasePoint

    April 1, 2015 - Medtronic plc today announced the initiation of the SPYRAL HTN Global Clinical Trial Program, a unique, phased clinical program studying renal denervation in uncontrolled hypertension. This announcement follows investigational device exemption approval by the U.S. Food and Drug Administration .

    Comment?

  8. EverFlex(TM) Peripheral Stent from Medtronic Delivers Sustained Patency in Long, Complex LesionsRead the original story

    Apr 1, 2015 | PressReleasePoint

    Three-Year Data from DURABILITY II Study Published inCatheterization and Cardiovascular Intervention Journal DUBLIN -- April 1, 2015 -- The EverFlex self-expanding peripheral stent system from Medtronic plc has proven to provide sustained patency in the treatment of long, complex lesions in the superficial femoral and popliteal arteries, according to the three-year results of the DURABILITY II study, which are reported in the recent issue of Catheterization and Cardiovascular Intervention. The EverFlex self-expanding stent system is a nitinol stent system that expands to a predetermined diameter to re-open narrowed regions of the SFA and proximal popliteal arteries that supply blood to the legs.

    Comment?

  9. 8 New Military Technologies to Make a Stronger WarriorRead the original story w/Photo

    Mar 31, 2015 | Kiplinger Online

    Already the most technologically advanced in the world, the U.S. military continues to develop new technologies for gathering intelligence, attacking enemy positions and defending American lives and interests. Some of the most innovative work focuses on soldiers themselves-amazing breakthroughs to help protect, strengthen and heal them during and after deployment.

    Comment?

  10. Medtronic CoreValveA System Receives FDA Approval for Transcatheter Valve-In-Valve ProceduresRead the original story

    Mar 31, 2015 | PR-inside.com

    First TAVR Device Indicated for Replacement of Failed Surgical Heart Valves Expands Patient Population That Can Benefit from Minimally Invasive Procedure DUBLIN - March 31, 2015 - Medtronic plc today announced the U.S. Food and Drug Administration approval of the CoreValve System for valve-in-valve procedures in patients whose surgical aortic heart valves have failed. The CoreValve System is the first transcatheter heart valve approved in the U.S. for VIV procedures in both high and extreme risk patients who have limited options or may otherwise go untreated.

    Comment?

  11. Medtronic Announces Japanese Regulatory Approval of CoreValveA SystemRead the original story

    Mar 30, 2015 | PR-inside.com

    March 30, 2015 - Medtronic plc today announced Japanese regulatory approval for the self-expanding transcatheter CoreValve System for patients with severe aortic stenosis unable to undergo surgery, and for whom treatment with the CoreValve is determined to be the best option. Japanese regulatory authorities granted approval of the CoreValve system for transcatheter aortic valve implantation based on robust data from the CoreValve U.S. Pivotal Trials and the Medtronic CoreValve Japan Trial, which is the first study to evaluate a self-expandable transcatheter valve in the Japanese patient population.

    Comment?

  12. Medtronic acquires Boulder-based hearing-aid maker SophonoRead the original story w/Photo

    Mar 27, 2015 | The Boulder County Business Report

    Sophono makes hearing aids that work by using bone conduction. Rather than increasing volume and pushing air in the ear canal like normal hearing aids, Sophono's device includes a magnet implanted under the skin behind a patient's ear.

    Comment?

  13. Data Proves Cost Savings, Reduced Hospital Stay After Minimally-Invasive SurgeryRead the original story w/Photo

    Mar 27, 2015 | Surgical Products

    Adding to the clinical benefits and improved patient outcomes associated with minimally-invasive surgery , Medtronic plc today highlighted new data demonstrating that patients who underwent minimally invasive colon resection procedures were able to leave the hospital faster, visit their doctors less for follow up care and take less medicine than those who underwent open surgery. The findings, which were published in the March 25 online edition of JAMA Surgery , suggest that minimally invasive approaches offer compelling near- and long-term cost savings for the healthcare system and less trauma for patients.

    Comment?

  14. Medtronic Highlights New Data in JAMA Surgery Demonstrating...Read the original story

    Mar 25, 2015 | PressReleasePoint

    Study Shows Patients Who Underwent Laparoscopic Colon Resections Left Hospital Faster, Required Significantly Less Follow Up Care and Fewer Medicines Than Patients Who Underwent Open Surgery DUBLIN - March 25, 2015 - Adding to the clinical benefits and improved patient outcomes associated with minimally-invasive surgery , Medtronic plc today highlighted new data demonstrating that patients who underwent minimally invasive colon resection procedures were able to leave the hospital faster, visit their doctors less for follow up care and take fewer medicines1 than those who underwent open surgery.

    Comment?

  15. Biotech startup to fight diabetes on the cellular frontRead the original story w/Photo

    Mar 23, 2015 | Boston.com

    Anew Cambridge biotech will be working on a treatment using stem cells that could let children and adults with Type 1 diabetes do something their bodies currently cannot: produce their own insulin, the hormone that keeps blood sugar levels in balance. Semma Therapeutics is already off to a strong start.

    Comment?

  16. What's driving the surge in donor advised funds?Read the original story w/Photo

    Mar 21, 2015 | Star Tribune

    The recent Medtronic acquisition of Covidien not only lowered the company's corporate tax rate, but also created a tax headache for longtime Medtronic shareholders - and a local miniboom in an increasingly popular type of family charity. In 2014, $4.8 million worth of Medtronic stock found its way into 58 donor-advised funds at the Minneapolis Foundation, including 18 newly established funds, according to Bill Sternberg, vice president of philanthropic services there.

    Comment?

  17. Protege GPS Self-Expanding Peripheral Stent System Receives FDA...Read the original story

    Mar 18, 2015 | PressReleasePoint

    March 18, 2015 -- Medtronic plc today announced that its ProtA gA GPS self-expanding peripheral stent system has received approval from the U.S. Food and Drug Administration for the treatment of stenotic lesions of the common and external iliac arteries. The news follows the nine-month results of the DURABILITY Iliac study, which were presented at the 2014 VIVA conference in Las Vegas.

    Comment?

  18. Medtronic Seeks Runners with Medical Technology for 2015 'Global Heroes' TeamRead the original story

    Mar 16, 2015 | PressReleasePoint

    APPLICATIONS NOW OPEN: Selected Runners Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October DUBLIN - March 16, 2015 - Medtronic announced today that applications are open to runners around the world who benefit from medical technology to represent their country on the tenth Medtronic Global Heroes team. All runners with eligible medical devices are welcome to apply, regardless of device manufacturer.

    Comment?

  19. Medtronic CoreValveA System Sustains Superior Survival Benefit Over Open Heart Surgery at Two YearsRead the original story

    Mar 15, 2015 | PressReleasePoint

    Investigators Conclude that Results Presented as ACC.15 Late-Breaking Clinical Trial Suggest that Self-Expanding TAVR Should be Considered New Standard of Care DUBLIN and SAN DIEGO - March 15, 2015 - Medtronic plc today unveiled new, highly anticipated two-year data from the High Risk Study of the CoreValve U.S. Pivotal Trial, which continued to show superior survival benefit at two years for transcatheter aortic valve replacement with the CoreValveA System compared to patients who underwent surgical aortic valve replacement .

    Comment?

  20. Medtronic to Initiate Clinical Study of Drug-Filled Stent Following Successful Preclinical ResultsRead the original story

    Mar 14, 2015 | PressReleasePoint

    Novel Platform Enables Controlled, Polymer-Free Drug Elution, Designed to Help Address Next-Generation Technology Challenges DUBLIN and SAN DIEGO - March 14, 2015 - Advancing its interventional coronary portfolio with breakthrough engineering concepts in device design and technology, Medtronic plc unveiled the preclinical outcomes of its novel Drug-Filled Stent at the 64th Annual Scientific Session of the American College of Cardiology . The preclinical data showed controlled and efficacious drug elution into the arterial wall without a polymer carrier, while reducing diameter stenosis and achieving complete stent coverage quickly without inflammation.

    Comment?